Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05155579
What this trial is testing

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Who this might be right for
Malaria
University of Oxford 594
Testing effectiveness (Phase 2)Study completedNCT00119197
What this trial is testing

Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata

Who this might be right for
Cholera
International Vaccine Institute 200
Early research (Phase 1)Study completedNCT05541861
What this trial is testing

Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 383
Testing effectiveness (Phase 2)Study completedNCT00115986
What this trial is testing

A/H5N1in Adult - Aventis

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 452
Early research (Phase 1)Study completedNCT07103369
What this trial is testing

A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
SinoMab BioScience Ltd 64
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345208
What this trial is testing

Safety and Immunogenicity of ID vs IM Rabies Vaccine

Who this might be right for
Rabies
International Centre for Diarrhoeal Disease Research, Bangladesh 90
Early research (Phase 1)Looking for participantsNCT07565090
What this trial is testing

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Who this might be right for
Sudan Virus Disease
International AIDS Vaccine Initiative 112
Testing effectiveness (Phase 2)Study completedNCT04168190
What this trial is testing

A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)

Who this might be right for
Pneumonia, Pneumococcal
Merck Sharp & Dohme LLC 600
Large-scale testing (Phase 3)Study completedNCT06049940
What this trial is testing

Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population

Who this might be right for
Tetanus
Sinovac Life Sciences Co., Ltd. 1,260
Large-scale testing (Phase 3)Study completedNCT06804590
What this trial is testing

A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Women Osteoporosis
Mabwell (Shanghai) Bioscience Co., Ltd. 280
Testing effectiveness (Phase 2)Looking for participantsNCT07507513
What this trial is testing

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Who this might be right for
Ulcerative Colitis (UC)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 288
Early research (Phase 1)Study completedNCT04199169
What this trial is testing

Safety and Immunogenicity of a Nipah Virus Vaccine

Who this might be right for
Nipah Virus Infection
Auro Vaccines LLC 192
Large-scale testing (Phase 3)Study completedNCT00489554
What this trial is testing

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
GlaxoSmithKline 230
Large-scale testing (Phase 3)Study completedNCT05158777
What this trial is testing

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Who this might be right for
Varicella
Shanghai Institute Of Biological Products 2,480
Testing effectiveness (Phase 2)Study completedNCT02360475
What this trial is testing

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 507
Large-scale testing (Phase 3)Study completedNCT00586612
What this trial is testing

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 313
Testing effectiveness (Phase 2)Study completedNCT03606512
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus
Janssen Vaccines & Prevention B.V. 38
Large-scale testing (Phase 3)Ended earlyNCT05228730
What this trial is testing

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).

Who this might be right for
COVID-19
Murdoch Childrens Research Institute 13
Large-scale testing (Phase 3)Study completedNCT00980655
What this trial is testing

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Vaccines, Pneumococcal Conjugate Vaccine
Pfizer 251
Testing effectiveness (Phase 2)Study completedNCT02464163
What this trial is testing

Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older

Who this might be right for
Influenza
Protein Sciences Corporation 407
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation